This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Molina Healthcare to Waive Costs Related to COVID-19 Treatment
by Zacks Equity Research
Molina Healthcare (MOH) eliminates specific 'out-of-pocket' expenses related to coronavirus treatment and undertakes several other initiatives.
Anthem to Remove Costs Related to Coronavirus Treatment
by Zacks Equity Research
Anthem's (ANTM) decision to eliminate supplementary costs related to the coronavirus treatment bodes well for its members.
Humana to Waive Expenses Related to Coronavirus Treatment
by Zacks Equity Research
Humana (HUM) to excuse members' out-of-pocket costs for COVID-19 treatment.
Cigna (CI) Ramps up Efforts to Contain Coronavirus Spread
by Zacks Equity Research
Cigna (CI) actively expands service suite for customers, thereby, helping contain the virus spread.
UnitedHealth Offers Relief to Clients in Houston Amid Crisis
by Zacks Equity Research
UnitedHealth (UNH) expands its contract with Methodist to provide its members access to the hospital's doctors amid the global crisis.
Top Analyst Reports for JPMorgan, Mastercard & Qualcomm
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including JPMorgan Chase (JPM), Mastercard (MA) and Qualcomm (QCOM).
Humana (HUM) Continues to Ride on Medicare Business Momentum
by Zacks Equity Research
Humana (HUM) consistently thrives on the back of its well-performing Medicare business.
Cigna (CI) Down 7.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Cigna (CI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tenet Healthcare Rides on Inorganic Growth, Reduces Leverage
by Zacks Equity Research
Tenet Healthcare (THC) gains traction from strategic initiatives and declining debt load.
Cigna Ties Up With Houston Methodist to Provide Quality Care
by Zacks Equity Research
Cigna (CI) partners Houston Methodist to provide affordable health plans to its members.
Anthem's (ANTM) Beacon Health Buyout to Bolster Portfolio
by Zacks Equity Research
Anthem (ANTM) carries on with its acquisition spree, the latest being the purchase of Beacon Health.
Earnings Season Scorecard and Analyst Reports for Mastercard, Comcast & Others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), Comcast (CMCSA) and Honeywell International (HON).
Company News for Feb 7, 2020
by Zacks Equity Research
Companies in the news are: BMY, CI, NOK, CAH
Is Cigna (CI) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Is (CI) Outperforming Other Finance Stocks This Year?
Cigna (CI) Q4 Earnings and Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
Cigna (CI) Q4 results reflect revenue and membership growth on the back of Express Scripts acquisition.
Cigna (CI) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Cigna's (CI) earnings performance is likely to have gained from the accretive Express Scripts acquisition.
Cigna (CI) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Cigna (CI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Add BioDelivery Stock to Your Portfolio
by Zacks Equity Research
Here are five reasons which make BioDelivery (BDSI)) a good investment option in 2020.
Q4 Earnings Scorecard and Research Reports on Netflix, Chevron & Others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Chevron (CVX), Netflix (NFLX) and NextEra Energy (NEE).
Healthcare in Retirement: Personal Finance 101
by Madeleine Johnson
Like all retirement-related things, healthcare is very important to plan for (financially and emotionally). Here's what retirees need to know about healthcare in your nest egg years.
Top Stocks to Invest in America's Aging Workforce
by Tirthankar Chakraborty
Percentage of Americans aged 65 and above will climb to 21% by 2030 from 15% in 2018. In fact, the number of Americans aged more than 60 have already tripled since 1950.
Why is Hold Strategy Appropriate for CNO Financial (CNO) Now?
by Zacks Equity Research
Riding high on its growing top line, reducing costs and an impressive capital position, CNO Financial (CNO) is well placed to benefit its investors.
UnitedHealth (UNH) Q4 Earnings Beat on Revenue Growth
by Zacks Equity Research
UnitedHealth's (UNH) Q4 results reflect strong contribution from its health benefits and service segments.
Top Ranked Growth Stocks to Buy for January 15th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 15th
Cigna, Oscar Team Up to Offer Health Aids to Small Businesses
by Zacks Equity Research
Cigna (CI) partners with Oscar to provide health solutions for small businesses.